Pregnant women at higher risk for HIV, Uganda study finds

September 29, 2005

The risk of acquiring HIV rises during pregnancy, according to a study of women in Uganda's Rakai District led by researchers at the Johns Hopkins Bloomberg School of Public Health. The increased risk for acquiring HIV remained even after researchers controlled for behavior and other factors that contribute to HIV risk. The findings, which are published in the September 30, 2005, edition of The Lancet, suggest that the increased risk was likely due to biological changes during pregnancy.

"We cannot generalize our findings beyond the Rakai setting and it would be important for other investigators to verify our results. However, if women are at increased risk of HIV acquisition during pregnancy, our findings represent a public-health problem, both for the mother and possibly her unborn infant," said the study's lead author Ronald Gray, MD, the Robertson Professor of Reproductive Epidemiology in the Bloomberg School's Department of Population and Family Health Sciences. "We believe that it would be prudent to warn women of this potential risk of HIV acquisition during pregnancy and promote safe sex or sexual abstinence where feasible."

The study supports the findings of two previous studies that reported a greater risk of acquiring HIV during pregnancy than after delivery. However, neither study accounted for risk factors that contribute to HIV risk.

Gray and his colleagues assessed 2,188 HIV-negative women who were sexually active and were pregnant or breastfeeding, and compared their rates of HIV acquisition to 8,473 women who were neither pregnant nor lactating. They compared the incidence rates of HIV during pregnancy and breastfeeding with the rates during intervals when pregnancy and breastfeeding were absent. The sexual behaviors of husbands of married women in the study were also assessed.

According to the investigators, the rate of HIV acquisition was higher during intervals of pregnancy than during breastfeeding or during intervals with neither. The results of the study showed HIV incidence rates during pregnancy were 2.3 percent per year whereas HIV incidence rates were 1.3 percent per year during breastfeeding and 1.1 percent per year for women who were not pregnant or breastfeeding. The risk for HIV remained higher even after the investigators adjusted for other HIV risk factors.

"It is unlikely that the change in HIV risk we observed is due to sexual behaviors. It may be attributed to hormonal changes affecting the genital tract mucosa or immune responses," said Gray.
-end-
Additional study authors include Xianbin Li and Henna Brahmbhatt of the Johns Hopkins Bloomberg School of Public Health; Godfrey Kigozi, Fred Nalugoda and Mohamed Kiddugavu of the Rakai Health Sciences Programme at the Uganda Virus Research Institute; David Serwaddo and Fred Wabwire-Mangen of the Institute for Public Health at Makerere University; Nelson Sewankambo at the Makerere University School of Medicine; Thomas C. Quinn and Steven J. Reynolds of the Johns Hopkins School of Medicine; and Maria J. Wawer of the Mailman School of Public Health at Columbia University.

The research was funded by grants from the National Institute of Allergy and Infectious Diseases, the National Institute of Child Health and Development, the Henry Jackson Foundation for the Advancement of Military Medicine, the United States Department of Defense and the Bill and Melinda Gates Institute of Population and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health.

Johns Hopkins University Bloomberg School of Public Health

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.